ganciclovir (cytovene) Report issue

Small molecule Orphan Drug FDA Approved FDA Priority Review FDA

Active Ingredient History

NOW
  • Now
There is no information in the literature about pharmacological and biological application of definite isomer: R of valganciclovir. However, is known, that valganciclovir, existing, as a mixture of R and S diasteriomers, is the active ingredient in Valcyte, which is used as an antiviral medication given to patients who have a high chance of developing cytomegalovirus (CMV) disease after receiving a heart, kidney, or kidney-pancreas transplant. It was proposed, that stable aqueous solutions of valganciclovir can be prepared in aqueous solutions at acidic pHs but these solutions will exist as a mixture of isomers: R and S   NCATS

More Chemistry

Drug Pricing (per unit)

United States

$4.6260 - $119.5540

Australia

$24.5569
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

2-(6-amino-purin-9-ylmethoxy)-propane-1,3-diol | 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-1h-purin-6(9h)-one | 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-3h-purin-6(9h)-one | 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-9h-purin-6-ol | 2-amino-9-(2-hydroxy-1-hydroxymethyl-ethoxymethyl)-1,9-dihydro-purin-6-one | 2-amino-9-(2-hydroxy-1-hydroxymethylethoxymethyl)-6,9-dihydro-1h-6-purinone | 9-[(1,3-dihydroxy-2-propoxy)methyl]guanine | 9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)guanine | bw-759u | cymevene | cytovene | denosine | ga2 | ganciclovir | ganciclovir sodium | ganciclovirum | gancyclovir | hydroxyacyclovir | natclovir | rs-21592 | rs-21592 sodium | virgan | vitrasert | zirgan

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue